PepTalk 2022 | San Diego, CA & Virtual
Jan 17, 2022
Absci CTO Matthew Weinstock will be presenting, “Enabling the Discovery and Production of Next-Generation Biologics via Synthetic Biology and Artificial Intelligence” on Wednesday, January 19th at 10:05 AM PST as part of the Recombinant Protein Expression and Production track. For more information please visit the conference home page or find the full agenda here.
Presentation title:
Enabling the Discovery and Production of Next-Generation Biologics via Synthetic Biology and Artificial Intelligence
Presentation abstract:
Recent advances in synthetic biology and artificial intelligence promise to dramatically impact the way that pharmaceuticals are developed. In this presentation I will discuss how Absci is leveraging the power of these technologies to address key pain points in both how protein-based biologics are discovered as well as how cell lines for manufacturing are designed.
Presenter: Matthew Weinstock, CTO, Absci